Skip to Main Content

Geron Corporation

Geron Corporation develops medicines for blood cancers, focusing on myeloid hematologic malignancies and utilizing telomerase inhibition as a treatment strategy.

Site Profile
Security Setup
CMissing 4 of 7 security checks
  • No HSTS
  • No X-Frame-Options
  • No X-Content-Type
  • No Referrer-Policy

Passing

SSL certificate · HTTPS enforced · TLS 1.3

Not Set

Content-Security-Policy · Permissions-Policy

Last scanned

Geron-Corporation Homepage 1440px